Efficacy of durvalumab and safety by treatment period in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (Flot) chemotherapy in resectable gastric/gastroesophageal junction (G/gej) cancer
Wainberg, Z. A., Van Cutsem, E., Götze, T., Sendur, M. A. N., Al-Farhat, Y., Wysocki, P. J., Mansoor, W., Bitzer, … Read More
